PEGLAX ORANGE

国: イスラエル

言語: 英語

ソース: Ministry of Health

即購入

公開評価報告書 公開評価報告書 (PAR)
08-06-2022

有効成分:

POLYETHYLENE GLYCOL 3350

から入手可能:

NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL

ATCコード:

A06AD15

医薬品形態:

POWDER FOR ORAL SOLUTION

構図:

POLYETHYLENE GLYCOL 3350 99.365 %W/W

投与経路:

PER OS

処方タイプ:

Not required

製:

BEN SHIMON FLORIS LTD, ISRAEL

治療領域:

MACROGOL

適応症:

Treatment of constipation.

承認日:

2015-10-31

情報リーフレット

                                PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS
(PREPARATIONS) – 1986
This medicine is dispensed without a doctor’s prescription
PEGLAX NEUTRAL
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.973% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
PEGLAX ORANGE
Powder for preparing an oral solution
THE ACTIVE INGREDIENT AND ITS CONCENTRATION:
Polyethylene glycol 3350, 99.365% w/w
INACTIVE INGREDIENTS:
see section 6 in the leaflet – “
ADDITIONAL INFORMATION
”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE.
This leaflet contains concise
information about the medicine. If you have additional questions,
refer to the doctor or the
pharmacist.
Use the preparation according to the instructions in the dosage
section of this leaflet.
Consult the pharmacist if you need more information. Refer to the
doctor if signs of the
ailment (symptoms) worsen or do not improve.
Peglax does not contain sugar and is therefore suitable for diabetics.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for treatment of constipation. Peglax softens
the stool by
increasing the stool water content, causes normal intestinal activity
and thus relieves
constipation.
THERAPEUTIC CLASS:
Osmotic laxative.
2. BEFORE USING THE MEDICINE
DO NOT USE THIS MEDICINE IF:
•
You are sensitive (allergic) to the active ingredient (polyethylene
glycol 3350) or
to any of the other ingredients this medicine contains (for a list of
inactive
ingredients see section 6 in leaflet – “Additional
information”).
•
You suffer from an intestinal or colon disease (such as ulcerative
inflammation of
the large intestine, Crohn’s disease).
•
You suffer from abdominal pain of undetermined cause.
•
You have or suspect you may have gastrointestinal perforation.
•
You have or suspect you may have bowel obstruction.
SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE
•
The medicine contains polyethylene glyco
                                
                                完全なドキュメントを読む
                                
                            

他の言語のドキュメント

情報リーフレット 情報リーフレット アラビア語 13-12-2022
情報リーフレット 情報リーフレット ヘブライ語 13-12-2022

この製品に関連するアラートを検索

ドキュメントの履歴を表示する